MedTrace Logo

A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention

NCT01924806 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2020-02-28

Study results available
· View outcomes & findings →

Summary

A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention

Conditions

  • Lower Leg Wound

Interventions

DEVICE

WoundWand™ Debridement Device

Group I - Electrical energy that removes necrotic, ischemic, and/or infected tissue within a wound

DEVICE

Standard of Care sharp debridement

Group II - Sharp instruments that remove necrotic, ischemic, and/or infected tissue within a wound

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Luc Teot, M.D. Phd. · Hopital Lapeyronie

  • Beate Hanson, MD, PhD · Vice President, Global Clinical Strategy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-04
Primary Completion
2015-02-09
Completion
2015-02-09

Countries

  • France
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01924806 on ClinicalTrials.gov